ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,407 Cr | ₹1,343 Cr | ₹1,206 Cr | ₹1,203 Cr | ₹1,031 Cr |
What is the latest Total Current Liabilities ratio of ABBOTT INDIA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,407 Cr |
| Mar2024 | ₹1,343 Cr |
| Mar2023 | ₹1,206 Cr |
| Mar2022 | ₹1,203 Cr |
| Mar2021 | ₹1,031 Cr |
How is Total Current Liabilities of ABBOTT INDIA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,407 Cr | 4.80 | |
| Mar2024 | ₹1,343 Cr | 11.33 | |
| Mar2023 | ₹1,206 Cr | 0.24 | |
| Mar2022 | ₹1,203 Cr | 16.72 | |
| Mar2021 | ₹1,031 Cr | - | |
Compare Total Current Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹58,985.6 Cr | -0.7% | -6% | -2.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,753.0 Cr | -0.2% | 1.1% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,205.0 Cr | 0.7% | -2.9% | 6.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,169.0 Cr | -0.9% | -1.6% | 13.6% | Stock Analytics | |
| CIPLA | ₹121,166.0 Cr | 0.7% | -2.4% | 4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,749.0 Cr | 2.2% | 2.8% | 2.8% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -0.7% |
-6% |
-2.9% |
| SENSEX | 0% |
0.1% |
3.9% |
You may also like the below Video Courses